Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-21.46	69.18	88.09
Graham Fair Price	31.53	5.61	4.27
PEG	-55.94	0.47	-1.07
Price/Book	-11.23	1.71	1.93
Price/Cash Flow	16.94	-12.21	-14.70
Prices/Earnings	-49.35	29.70	58.63
Price/Sales	-27.32	22.23	30.58
Price/FCF	16.94	-12.21	-14.70
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	23.02	0.56	0.45
Operating Margin	-27.55	0.42	0.58
ROA	75.74	< 0.005	< 0.005
ROE	< 0.005	0.01	75.26
ROIC	< 0.005	< 0.005	-16.41
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	0.18	-96.32
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	< 0.005	-0.12	2021.58
EPS QOQ	-0.55	0.63	14.95
FCF QOQ	0.19	-0.06	-67.60
Revenue QOQ	0.27	0.21	-19.71
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	371.59	< 0.005	-100.00
Days Sales Outstanding (DSO)	96.83	132.00	36.32
Inventory Turnover	0.24	39808520.00	16435949085.52
Debt/Capitalization	0.70	0.69	-0.93
Quick Ratio	0.84	0.94	12.30
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	9.91	9.84	-0.65
Cash	3.47	3.43	-1.24
Capex	-1.50	-1.68	-11.54
Free Cash Flow	-1.30	-1.38	-6.18
Revenue	0.63	0.76	21.35
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.14	0.94	-17.46
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	44.41	37.20	-16.24
Naive Interpretation	Member

06 - Financial Health · Bad

Rating